0
Signin
countryflagUS

18889881171

AAPL 169.89 0.5147% MSFT 399.04 -2.4495% GOOG 157.95 -1.9553% GOOGL 156.0 -1.9669% AMZN 173.67 -1.6535% NVDA 826.32 3.7087% META 441.38 -10.5613% TSLA 170.18 4.9652% TSM 136.58 2.7149% LLY 724.87 -1.0011% V 275.16 0.0509% AVGO 1294.42 2.9917% JPM 193.37 0.1502% UNH 493.86 1.3462% NVO 125.79 -0.2933% WMT 60.21 0.5679% LVMUY 167.91 -2.1618% XOM 121.35 0.2478% LVMHF 837.0 -2.6461% MA 462.11 -0.0843%

Eargo Inc

Healthcare US EAR

NoneUSD
-(-%)

Last update at 2024-04-09T03:57:47.368254Z

Day Range

--
LowHigh

52 Week Range

1.4716.80
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -157.38700M -157.75400M -39.85500M -44.48600M -33.79300M
Minority interest - - - - -
Net income -157.48700M -157.75400M -30.01500M -44.48600M -33.79300M
Selling general administrative 54.26M 49.88M 20.58M 12.47M 8.25M
Selling and marketing expenses 52.95M 85.76M 49.52M 35.73M 25.54M
Gross profit 14.26M 4.17M 47.28M 17.00M 11.74M
Reconciled depreciation 5.46M 4.20M 2.52M 1.53M 0.69M
Ebit -111.75900M -156.70700M -34.87100M -44.03600M -33.36900M
Ebitda -156.06600M -152.48400M -36.30800M -42.24700M -32.67400M
Depreciation and amortization -44.30700M 4.22M -1.43700M 1.79M 0.69M
Non operating income net other -45.07900M - -3.06400M - -
Operating income -111.75900M -156.70700M -34.87100M -44.03600M -31.57100M
Other operating expenses 149.01M 188.83M 104.03M 76.83M 54.73M
Interest expense 0.55M 1.07M 1.92M 0.71M 0.42M
Tax provision 0.10M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 1.20M 0.02M 0.04M 0.63M 0.16M
Net interest income 0.65M -1.04700M -1.88300M -0.08400M -0.26000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.10M 1.07M -2.07900M 0.34M -1.79800M
Total revenue 37.25M 32.12M 69.15M 32.79M 23.16M
Total operating expenses 126.02M 160.87M 82.15M 61.04M 43.31M
Cost of revenue 22.99M 27.96M 21.87M 15.79M 11.42M
Total other income expense net -45.62800M -1.04700M -4.98400M -0.45000M -2.22200M
Discontinued operations - - - - -
Net income from continuing ops -157.48700M -157.75400M -39.85500M -44.48600M -33.79300M
Net income applicable to common shares -157.48700M -157.75400M -30.01500M -44.48600M -33.79300M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 132.08M 160.11M 232.63M 27.30M 59.04M
Intangible assets 1.06M 1.68M - - -
Earning assets - - - - -
Other current assets 7.85M 0.62M 3.74M 1.60M 1.36M
Total liab 31.22M 90.95M 38.72M 183.41M 172.04M
Total stockholder equity 100.85M 69.16M 193.91M -156.10300M -112.99900M
Deferred long term liab - - - 1.20M -
Other current liab 18.12M 36.19M 16.36M 11.66M 1.69M
Common stock 0.00200M 0.00400M 0.00400M - -
Capital stock 0.00200M 0.00400M 0.00400M 0.00000M 0.00000M
Retained earnings -514.29900M -356.81200M -199.05800M -159.20300M -114.71700M
Other liab - - - 0.79M 0.38M
Good will 0.87M 0.87M - - -
Other assets 0.91M 1.21M 0.00214M 1.99M 0.40M
Cash 101.24M 110.50M 212.19M 13.38M 51.05M
Cash and equivalents - - - - -
Total current liabilities 25.25M 72.38M 23.72M 22.29M 12.66M
Current deferred revenue - 23.06M 0.31M 0.41M 0.07M
Net debt -94.63700M -87.85300M -196.15200M -1.13800M -44.06100M
Short term debt 0.63M 4.08M 1.03M 4.80M 5.72M
Short long term debt - 3.33M - 4.80M -
Short long term debt total 6.60M 22.65M 16.03M 12.25M 6.99M
Other stockholder equity 615.15M 425.97M 359.39M 162.30M 116.44M
Property plant equipment 7.44M 16.72M 9.11M 5.40M 2.95M
Total current assets 116.03M 139.63M 222.46M 19.91M 55.69M
Long term investments - - - - -
Net tangible assets 98.92M 66.61M 193.91M -156.10300M -112.99900M
Short term investments - - - - -
Net receivables 1.91M 12.55M 3.79M 2.05M 0.96M
Long term debt - 11.92M 14.84M 7.45M 6.99M
Inventory 5.04M 5.71M 2.74M 2.88M 2.16M
Accounts payable 6.50M 9.05M 6.02M 5.43M 5.17M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - -199.05800M -159.20300M -114.71700M
Additional paid in capital - - - - -
Common stock total equity 0.00200M - 0.00400M - -
Preferred stock total equity - - - - -
Retained earnings total equity -514.29900M - -199.05800M - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.91M 1.21M 1.06M 1.99M 0.40M
Deferred long term asset charges - - - - -
Non current assets total 16.05M 20.48M 10.18M 7.39M 3.35M
Capital lease obligations 6.60M 7.39M 1.20M - -
Long term debt total - - 14.84M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -3.08700M -7.58700M -5.07900M -3.85900M -2.54700M
Change to liabilities 0.59M 3.13M -0.17700M 0.68M 2.70M
Total cashflows from investing activities -3.08700M -7.58700M -5.07900M -3.85900M -2.54700M
Net borrowings 89.14M 89.14M 12.33M 5.00M -0.68900M
Total cash from financing activities 111.13M 4.36M 229.92M 5.15M 71.73M
Change to operating activities -37.03500M 34.32M 2.24M 3.04M 3.67M
Net income -157.48700M -157.75400M -39.85500M -44.48600M -33.79300M
Change in cash -9.26200M -101.68500M 198.80M -37.81700M 42.03M
Begin period cash flow 110.50M 212.19M 13.38M 51.20M 9.17M
End period cash flow 101.24M 110.50M 212.19M 13.38M 51.20M
Total cash from operating activities -117.30400M -98.45600M -26.04100M -39.10800M -27.14900M
Issuance of capital stock 27.60M 0.00000M 219.02M 0.86M 72.41M
Depreciation 5.46M 4.20M 2.52M 1.53M 0.69M
Other cashflows from investing activities -0.29600M - -3.45500M - -
Dividends paid - - - - -
Change to inventory 0.68M -2.97300M 0.14M -0.72000M -1.75000M
Change to account receivables 9.92M -18.36900M -4.09400M -1.08600M -0.31400M
Sale purchase of stock 27.73M - 217.59M - -
Other cashflows from financing activities 99.77M 4.36M 96.06M 5.15M 79.42M
Change to netincome 56.95M 38.98M 13.18M 2.25M 1.64M
Capital expenditures 3.09M 4.72M 5.08M 3.86M 2.55M
Change receivables 9.92M - -4.09400M - -
Cash flows other operating -33.41800M - 0.92M - -
Exchange rate changes - - - - -
Cash and cash equivalents changes -9.26200M - 198.80M - -
Change in working capital -29.22900M 16.11M -1.89100M 1.92M 4.31M
Stock based compensation 9.96M 27.73M 5.09M 1.34M 0.45M
Other non cash items 53.99M 1.48M 2.64M 0.30M 0.13M
Free cash flow -120.39100M -103.18000M -31.12000M -42.96700M -29.69600M

Fundamentals

  • Previous Close -
  • Market Cap53.36M
  • VolumeNone
  • P/E Ratio0.17
  • Dividend Yield-%
  • EBITDA-87.54500M
  • Revenue TTM41.11M
  • Revenue Per Share TTM2.28
  • Gross Profit TTM 14.26M
  • Diluted EPS TTM15.00

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EAR
Eargo Inc		 - -% - 0.17 - 1.30 1.18 0.36 -0.1453
ABT
Abbott Laboratories		 -0.03 0.03% 106.86 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 0.30 0.09% 337.15 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -1.13 1.41% 79.25 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 0.35 0.48% 73.26 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.

Eargo Inc

2665 North First Street, San Jose, CA, United States, 95134

Key Executives

Name Title Year Born
Mr. Christian Gormsen CEO, Pres & Director 1977
Mr. Adam Laponis Chief Financial Officer 1976
Mr. William H. Brownie Chief Operating Officer 1967
Mr. Daniel Shen Co-Founder and Chief Clinical & Science Officer NA
Mr. Mark Thorpe Chief Accounting Officer 1968
Mr. Tim Trine Ph.D. Chief Technology Officer NA
Mr. Nicholas S. Laudico Sr. VP of Corp. Strategy & Investor Relations NA
Ms. Christy La Pierre Chief Legal Officer & Sec. NA
Mr. Frederick D. Knight CCEP, M.B.A. Chief Compliance Officer NA
Mr. Pio Schunker Chief Marketing Officer NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).